Message from discussion
New Challenges for Use of Embryonic Stem Cells
Received: by 10.151.92.20 with SMTP id u20mr683757ybl.31.1301762031493;
Sat, 02 Apr 2011 09:33:51 -0700 (PDT)
X-BeenThere: advanced-cell-technology@googlegroups.com
Received: by 10.150.1.14 with SMTP id 14ls1330610yba.2.p; Sat, 02 Apr 2011
09:33:49 -0700 (PDT)
Received: by 10.151.48.19 with SMTP id a19mr989980ybk.48.1301762029079;
Sat, 02 Apr 2011 09:33:49 -0700 (PDT)
Received: by 10.150.73.31 with SMTP id v31msyba;
Sat, 2 Apr 2011 09:22:22 -0700 (PDT)
MIME-Version: 1.0
Received: by 10.91.196.14 with SMTP id y14mr943621agp.30.1301761342209; Sat,
02 Apr 2011 09:22:22 -0700 (PDT)
Received: by d28g2000yqf.googlegroups.com with HTTP; Sat, 2 Apr 2011 09:22:22
-0700 (PDT)
Date: Sat, 2 Apr 2011 09:22:22 -0700 (PDT)
In-Reply-To: <AANLkTi=HUmB1iV5OmuEXhg00twJEA7=yGtSpN8hOQ4J-@mail.gmail.com>
X-IP: 64.12.117.80
References: <AANLkTi=HUmB1iV5OmuEXhg00twJEA7=yGtSpN8hOQ4J-@mail.gmail.com>
User-Agent: G2/1.0
X-HTTP-Via: HTTP/1.1 (Velocity/3.1.2.1 [uScMs f p eN:t cCMp s ]), HTTP/1.1
spider-mtc-tg06.proxy.aol.com[400C70C6] (Prism/1.2.1), HTTP/1.1
cache-mtc-af16.proxy.aol.com[400C7550] (Traffic-Server/6.1.5 [uScM])
X-HTTP-UserAgent: Mozilla/4.0 (compatible; MSIE 8.0; AOL 9.0; AOLBuild
4327.5206; Windows NT 5.1; Trident/4.0; .NET CLR 1.0.3705; .NET CLR 1.1.4322;
Media Center PC 4.0; .NET CLR 2.0.50727; .NET CLR 3.0.4506.2152; .NET CLR
3.5.30729; .NET4.0C),gzip(gfe)
Message-ID: <be6e9554-0ba2-4fb8-94a3-55182350a86b@d28g2000yqf.googlegroups.com>
Subject: Re: New Challenges for Use of Embryonic Stem Cells
From: catchall <catchal...@aol.com>
To: Advanced Cell Technology <advanced-cell-technology@googlegroups.com>
Content-Type: text/plain; charset=ISO-8859-1
Content-Transfer-Encoding: quoted-printable
This is all old news. A summary of issues. What is not said is the
ACTive part the OBAMA administration is taking in clarifying the
misunderstandings about the science.
On Apr 1, 7:29=A0am, Dan Lynch <dandama...@gmail.com> wrote:
> Came in one of my alerts today.
>
> http://pharmtech.findpharma.com/pharmtech/Online+Only/New-Challenges-...
>
> --